Zobrazeno 1 - 2
of 2
pro vyhledávání: '"GM2A, GM2 activator protein"'
Autor:
Hitoshi Sakuraba, Youichi Tajima, Chikako Tasaki, Keisuke Kitakaze, Daisuke Tsuji, Takatsugu Hirokawa, Kohji Itoh
Publikováno v:
Biochemistry and Biophysics Reports
GM2 gangliosidoses are autosomal recessive lysosomal storage diseases (LSDs) caused by mutations in the HEXA, HEXB and GM2A genes, which encode the human lysosomal β-hexosaminidase (Hex) α- and β-subunits, and GM2 activator protein (GM2A), respect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95bd1c68f671c3365d83d2113ee44d6e
Autor:
Kitakaze K; Department of Medicinal Biotechnology, Institute of Biomedical Sciences, Graduate School of Pharmaceutical Science, Tokushima University, 1-78-1, Tokushima 770-8505, Japan., Tasaki C; Department of Medicinal Biotechnology, Institute of Biomedical Sciences, Graduate School of Pharmaceutical Science, Tokushima University, 1-78-1, Tokushima 770-8505, Japan., Tajima Y; Molecular Medical Research Project, Department of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan., Hirokawa T; Molecular Profiling Research Center for Drug Discovery (molprof), National Institute of Advanced Industrial Science and Technology (AIST), Tokyo 135-0064, Japan., Tsuji D; Department of Medicinal Biotechnology, Institute of Biomedical Sciences, Graduate School of Pharmaceutical Science, Tokushima University, 1-78-1, Tokushima 770-8505, Japan., Sakuraba H; Department of Clinical Genetics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan., Itoh K; Department of Medicinal Biotechnology, Institute of Biomedical Sciences, Graduate School of Pharmaceutical Science, Tokushima University, 1-78-1, Tokushima 770-8505, Japan.
Publikováno v:
Biochemistry and biophysics reports [Biochem Biophys Rep] 2016 Jun 08; Vol. 7, pp. 157-163. Date of Electronic Publication: 2016 Jun 08 (Print Publication: 2016).